REVIEW
|
doi:10.20944/preprints202403.1011.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
retinoblastoma; RB1; E2F; Targeted Therapy; Therapeutic Vulnerabilities; Spliceosome; Cell Cycle; Epigenetic Regulators; Ubiquitin-Proteasome Pathway
Online: 18 March 2024 (10:29:38 CET)